All In Biotech

Drug Trial Radar · NCT02010333

A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice Infestation

A Pediatric Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

Last checked: Nov 20, 2026Latest source record: May 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

22

Actual

Start

Apr 2013

Primary completion

Jul 2014

Study completion Aug 2014

Sponsor

Sponsor type
Industry
First posted
Dec 12, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 months, up to 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the study is to evaluate safety and tolerability of a single application of Ha44 Gel 0.74% w/w for the treatment of head lice. Secondary purpose is to evaluate PK of Ha44 and benzyl alcohol under conditions of maximal exposure in pediatric population.

Conditions

  • Head Lice Infestation

Interventions

  • Ha44 Gel 0.74% w/wDrug

    HA44 Gel 0.74% comprises of Abametapir as the active pharmaceutical ingredient and Benzyl Alcohol as one of the excipients.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of Ha44 GelTime frame: 8 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Universal Biopharma Research Institute

    Dinuba, California

  • Axis Clinical Trials

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.